TrendFlares logo

Gritstone bio, Inc. (GRTS)

$0.57 3.12% $0.02 Healthcare

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors comprising metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and shared neoantigen-positive tumors. In addition, it develops CORAL, a SARS-CoV-2 vaccine platform designed to deliver spike and additional SARS-CoV-2 T cell epitopes for protection and broader immunity against SARS-CoV-2 variants; and a therapeutic vaccine candidate designed to treat and cure human immunodeficiency virus (HIV) infection. It has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

$66.79M

Dr. Andrew R. Allen BCh, BM, M.D., MA, MRCP, Ph.D.

193.00

EmeryVille, CA

Sep 28, 2018

-0.52

$-1.09

2.18

2.54

-7,825.47%

-0.60

0.00

3.62

38.92

2.54

-93.33%

-328.51%

Downtrend

Similar stocks (17)

BridgeBio Pharma, Inc.

BBIO

$26.72 2.93%
Downtrend

Edgewise Therapeutics, Inc.

EWTX

$28.01 46.78%
Uptrend

Erasca, Inc.

ERAS

$2.96 2.60%
Uptrend

Annexon, Inc.

ANNX

$7.00 1.01%
Uptrend

Allogene Therapeutics, Inc.

ALLO

$3.00 4.17%
Downtrend

C4 Therapeutics, Inc.

CCCC

$6.90 8.15%
Neutral

G1 Therapeutics, Inc.

GTHX

$7.15 0.00%
Uptrend

Corvus Pharmaceuticals, Inc.

CRVS

$5.70 4.01%
Uptrend

Heron Therapeutics, Inc.

HRTX

$2.08 6.41%
Downtrend

Fulcrum Therapeutics, Inc.

FULC

$3.49 1.46%
Downtrend

Sangamo Therapeutics, Inc.

SGMO

$0.91 8.87%
Uptrend

Generation Bio Co.

GBIO

$2.79 7.69%
Downtrend

Annovis Bio, Inc.

ANVS

$8.85 5.88%
Downtrend

Leap Therapeutics, Inc.

LPTX

$2.90 0.69%
Neutral

Kronos Bio, Inc.

KRON

$0.95 3.29%
Downtrend

Passage Bio, Inc.

PASG

$0.70 -0.16%
Downtrend

Kezar Life Sciences, Inc.

KZR

$0.58 0.59%
Downtrend

ETF Exposure (12)

ETFMG Treatments, Testing and Advancements ETF

GERM

0.13%

$19.16 -0.29%
Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

7.349e-5%

$34.16 1.88%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.43 -0.28%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.42 -0.28%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.42 -0.26%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$136.02 0.03%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$96.13 -0.25%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$96.11 -0.25%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.99 -0.24%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.43 1.83%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.97 -0.24%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$183.14 2.12%
Uptrend